B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of AMETEK, Inc. (NYSE:AME - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 60,363 shares of the technology company's stock, valued at approximately $10,364,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Price T Rowe Associates Inc. MD boosted its holdings in AMETEK by 0.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 6,536,231 shares of the technology company's stock worth $1,195,478,000 after purchasing an additional 44,899 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of AMETEK by 34.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,602,753 shares of the technology company's stock worth $600,615,000 after buying an additional 926,657 shares during the last quarter. Boston Partners grew its holdings in shares of AMETEK by 3.0% during the 1st quarter. Boston Partners now owns 3,063,588 shares of the technology company's stock valued at $560,278,000 after purchasing an additional 90,271 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of AMETEK by 8.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,882,166 shares of the technology company's stock valued at $313,777,000 after purchasing an additional 148,447 shares during the last quarter. Finally, Principal Financial Group Inc. increased its position in shares of AMETEK by 72.0% in the third quarter. Principal Financial Group Inc. now owns 1,680,309 shares of the technology company's stock valued at $288,526,000 after acquiring an additional 703,501 shares during the period. 87.43% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have issued reports on AME shares. StockNews.com cut shares of AMETEK from a "buy" rating to a "hold" rating in a research report on Friday, November 15th. Truist Financial upped their target price on shares of AMETEK from $219.00 to $221.00 and gave the stock a "buy" rating in a research note on Friday, November 1st. Robert W. Baird boosted their price objective on shares of AMETEK from $166.00 to $186.00 and gave the company a "neutral" rating in a report on Monday, November 4th. Royal Bank of Canada decreased their price objective on shares of AMETEK from $216.00 to $215.00 and set an "outperform" rating for the company in a report on Friday, August 2nd. Finally, Mizuho boosted their price objective on shares of AMETEK from $190.00 to $200.00 and gave the company an "outperform" rating in a report on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, AMETEK has an average rating of "Moderate Buy" and a consensus target price of $197.86.
Read Our Latest Research Report on AMETEK
Insider Buying and Selling
In other news, Director Steven W. Kohlhagen sold 1,460 shares of the stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $171.59, for a total value of $250,521.40. Following the sale, the director now owns 23,349 shares of the company's stock, valued at approximately $4,006,454.91. This represents a 5.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider David F. Hermance sold 6,243 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $190.99, for a total transaction of $1,192,350.57. Following the completion of the sale, the insider now directly owns 36,731 shares in the company, valued at approximately $7,015,253.69. This represents a 14.53 % decrease in their position. The disclosure for this sale can be found here. 0.61% of the stock is owned by company insiders.
AMETEK Stock Performance
AME stock traded down $0.13 during midday trading on Wednesday, reaching $193.33. 995,244 shares of the company's stock traded hands, compared to its average volume of 1,154,345. The stock has a market cap of $44.72 billion, a P/E ratio of 33.68, a PEG ratio of 3.15 and a beta of 1.16. AMETEK, Inc. has a 52-week low of $149.03 and a 52-week high of $196.70. The stock's 50-day moving average is $175.30 and its 200 day moving average is $170.32. The company has a current ratio of 1.39, a quick ratio of 0.84 and a debt-to-equity ratio of 0.18.
AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The technology company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.04. AMETEK had a net margin of 19.27% and a return on equity of 16.88%. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.71 billion. During the same period in the prior year, the business posted $1.64 earnings per share. The company's revenue was up 5.3% on a year-over-year basis. As a group, analysts anticipate that AMETEK, Inc. will post 6.81 EPS for the current year.
AMETEK Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Friday, December 6th will be given a dividend of $0.28 per share. The ex-dividend date is Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.58%. AMETEK's dividend payout ratio is 19.51%.
AMETEK Company Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Stories
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report